U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07164703) titled 'A Real-World Study of Precision Treatment for Advanced Cholangiocarcinoma Based on Molecular Subtyping' on Aug. 31.
Brief Summary: This is a multi-center, real-world study aiming to evaluate the efficacy and safety of precision treatment for advanced cholangiocarcinoma (CCA) with different molecular subtypes.
Study Start Date: Oct. 01
Study Type: OBSERVATIONAL
Condition:
Advanced Cholangiocarcinoma (Part 1)
Intervention:
DRUG: Targeted drugs or immunotherapies for cholangiocarcinoma based on targetable gene mutations.
Targeted drugs or immunotherapies for cholangiocarcinoma based on targetable gene mutations.
Recruitment St...